Reactive with synaptophysin expressed in CHO cells
| Inventor | Institute |
|---|---|
| William Honer | The University of British Columbia |
| Cat. #: | 158419 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Genitourinary cancer |
| Research Fields: | Cell signaling and signal transduction;Neurobiology |
| Application: | ELISA ; ICC ; WB |
| Target: | Synaptophysin |
| Reactivity: | Human ; Pig ; Hamster ; Rat ; Feline |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Reactive with synaptophysin expressed in CHO cells |
|---|---|
| Conjugation: | Unconjugated |
| Target background: | Reactive with synaptophysin expressed in CHO cells |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Barr et al. 2003. Int J Neuropsychopharmacol. 6(1):23-34. PMID: 12899733. Sawada et al. 2002. Mol Psychiatry. 7(5):484-92. PMID: 12082566. Zhang et al. 2002. J Neurosci. 22(14):6052-61. PMID: 12122066. Ramirez et al. 2001. J Neural Transm (Vienna). 108(7):809-26. PMID: 11515747. Takeda et al. 1998. Am J Pathol. 152(2):367-72. PMID: 9466562. Honer et al. 1997. Neuroscience. 78(1):99-110. PMID: 9135092. Beach et al. 1997. Acta Neuropathol. 93(2):146-53. PMID: 9039461. Wakabayashi … |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.